Published in Transplantation on January 01, 1987
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc (1991) 1.06
Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology (1990) 1.05
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. Transplant Proc (1991) 1.01
Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience. Br J Cancer (1999) 0.89
Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc (1988) 0.86
Transitional cell carcinoma in renal transplant recipients. World J Surg (2003) 0.82
Cyclosporin A enhances locoregional metastasis of the CC531 rat colon tumour. J Cancer Res Clin Oncol (1997) 0.78
A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience. World J Urol (2014) 0.78
Cyclosporin-A associated malignancy. Clin Ophthalmol (2007) 0.76
DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance? Carcinogenesis (2009) 0.76
Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy? J Ophthalmic Inflamm Infect (2013) 0.75
Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model. Immunology (1999) 0.75
Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J (2001) 0.75
Lymphoproliferative disorders in organ transplant recipients. Eur Radiol (1997) 0.75
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
De-novo brain tumours in renal-transplant recipients. Lancet (1971) 2.36
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg (1971) 2.14
Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95
Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90
Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation (1972) 1.80
Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79
Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation (1979) 1.64
Tumor incidence in human allograft recipients. Transplant Proc (1979) 1.64
Renal homotransplantation in pediatric patients. Pediatrics (1971) 1.59
Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer (1986) 1.58
Cancers complicating organ transplantation. N Engl J Med (1990) 1.57
Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation (2002) 1.56
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Parenthood following renal and hepatic transplantation. Transplantation (1980) 1.35
Major colonic problems in human homotransplant recipients. Arch Surg (1970) 1.33
Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery (1978) 1.32
Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet (1970) 1.32
Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol (1975) 1.32
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
The price of immunotherapy. Curr Probl Surg (1981) 1.29
Immunosuppression and cancer. Transplant Proc (1973) 1.26
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Parenthood in renal homograft recipients. JAMA (1971) 1.24
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Cutaneous complications in immunosuppressed renal homograft recipients. JAMA (1974) 1.21
Perspectives in organ transplantation. Antibiot Chemother (1969) 1.19
Immunosuppression and malignant neoplasms. N Engl J Med (1970) 1.18
Depressed immunity and the development of cancer. Clin Exp Immunol (1981) 1.17
Second malignant neoplasms associated with immunosuppressive medications. Cancer (1976) 1.16
A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16
Clinical liver transplantation. Transplant Rev (1969) 1.13
The occurrence of malignant tumors in immunosuppressed states. Prog Allergy (1986) 1.13
Occurrence of cancer in immune deficiencies. Cancer (1974) 1.10
Immunopathological studies of orthotopic human liver allografts. Lancet (1972) 1.07
Parenthood in kidney and liver transplant recipients. Transplant Proc (1981) 1.06
Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet (1986) 1.06
Tumors arising in organ transplant recipients. Adv Cancer Res (1978) 1.04
Use of living donors in kidney transplantation in man. Arch Surg (1970) 1.04
Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc (1973) 1.04
Cerebral neoplasms associated with renal transplantation. Arch Neurol (1970) 1.03
Air embolism after central venous catheterization. Surg Gynecol Obstet (1984) 1.03
Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation (1997) 1.03
Transplantation of kidneys containing primary malignant tumors. Transplantation (1973) 1.02
Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc (1971) 1.00
Airless paint gun injuries of the hand: a clinical and experimental study. Plast Reconstr Surg (1967) 0.99
Malignancies associated with renal transplantation. Urology (1977) 0.99
Development of cancer as a complication of clinical transplantation. Transplant Proc (1977) 0.98
The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet (1973) 0.98
Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98
Jejunal rupture caused by a Sengstaken-Blakemore tube. Gastroenterology (1982) 0.97
Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc (1971) 0.97
Personal experience with orthotopic liver transplantation. Transplant Proc (1972) 0.96
The effect of hyperbaric oxygen upon aerobic bacteria. I. In vitro studies. Can J Microbiol (1966) 0.95
Renal transplantation for Wilms tumor: report of 20 cases. J Urol (1979) 0.94
Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation (1984) 0.94
Carcinoid tumor of the biliary system. Case report and literature review. Dig Dis Sci (1987) 0.93
Cancer in immunosuppressed patients. Transplant Proc (1984) 0.93
Malignant lymphomas in transplantation patients: a review of the world experience. Int Z Klin Pharmakol Ther Toxikol (1970) 0.93
Parenthood following renal transplantation. Kidney Int (1980) 0.93
The incidence of malignancies in transplant recipients. Transplant Proc (1975) 0.93
Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. J Am Coll Cardiol (1998) 0.93
Chemical immunosuppression and human cancer. Cancer (1974) 0.93
Antimurine antibody formation following OKT3 therapy. Transplantation (1990) 0.91
Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc (1973) 0.91
Psychiatric experience with patients receiving renal nad hepatic transplants. Semin Psychiatry (1971) 0.90
Malignant lymphomas in organ transplant recipients. Transplant Proc (1981) 0.89
Psychiatric aspects of hepatic transplantation. Transplantation (1983) 0.89
A summary of the status of de novo cancer in transplant recipients. Transplant Proc (1972) 0.88
Cyclosporine and oncogenesis. Mt Sinai J Med (1987) 0.87
Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature. Clin Transplant (1998) 0.86
Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation (1996) 0.86
Fate of tumors transplanted with a renal allograft. Transplant Proc (1975) 0.86
Development and incidence of cancer following cyclosporine therapy. Transplant Proc (1986) 0.86
Upper extremity complications of axillofemoral grafts. Am J Surg (1978) 0.85
The prospect of organ transplantation in cancer surgery. Proc Natl Cancer Conf (1970) 0.85
Hyperparathyroidism following parathyroid autotransplantation. Surgery (1979) 0.85
Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol (1983) 0.84
Clinical course of malignancies in renal transplant recipients. Cancer (1993) 0.84
Development of cancer in transplantation patients. Adv Surg (1978) 0.83
Selected topics on antilymphocyte serum. Fed Proc (1970) 0.83
Testicular complications following renal transplantation. Ann Surg (1972) 0.83
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation (1992) 0.82
HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol (2000) 0.82
A reappraisal of the microcirculation during general hypothermia. Surgery (1965) 0.82
Solid tumors in cardiac allograft recipients. Ann Thorac Surg (1995) 0.82
Skin disorders in organ transplant recipients. External anogenital lesions. Arch Dermatol (1997) 0.82
Immunosuppression and skin cancer. Clin Plast Surg (1980) 0.81